Log In
BCIQ
Print this Print this
 

BBI-5000

  Manage Alerts
Collapse Summary General Information
Company Brickell Biotech Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDermatitis
Indication DetailsTreat moderate to severe atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today